#ACR21 Abst#0449: Ever wish you had a tool to help you predict which PsA pts will progress to radiographic damage? ➡️Proteomic approaches identified 103 candidate biomarker peptides related to 69 proteins that can potentially do so! @Rheumnow @uptoTate https://t.co/uUsZlBLTWC

• https://bit.ly/31DjDaJf

#ACR21 Abst#0452 ⭐️Total Body PET/CT (TB-PET/CT) as a tool to identify subclinical PsA at the point of transition from psoriasis (PsO). ➡️Should all pts w/ new dx of PsO have a baseline TB-PET/CT to identify early PsA? #ACRBest @Rheumnow @uptoTate https://t.co/IuxVuJgFSd https://t.co/AIuH9CIucy

• Total-Body 18F-FDG PET/CT Imaging: A Tool for Diagnosis and Quantifying Inflamm…

#ACR21 Abst#0182 Does tenderness in non-swollen joints of PsA or RA pts portend inflammation & radiographic damage? ⭐️NO, except in early PsA! ➡️Abnormal PDUS associated w/ radiographic progression vs tenderness otherwise #ACRBest @Rheumnow @uptoTate https://t.co/iB1E0SL45e https://t.co/3Q30LeCMH4

• Tenderness and Radiographic Progression in Rheumatoid Arthritis and Psoriatic A…

⁦@JointMD⁩ shares his thoughts on IL23, IL17, TNF inh- where/when/how we might use them. ⁦@RheumNow⁩ #acr21 https://t.co/mVw05iFPhF

• PsA Perspectives - IL-23: Dr. Eric Ruderman - YouTube

👉Get contrast if ordering an MRI to eval for inflamm. arthritis 👉Heel spur vs. enthesitis? Look for erosions at dorsum of calcaneus & other signs of inflamm 👉DISH vs. axial PsA? DISH➡️contiguous bony ossific'n up anterior margin of the vertebral bodies; PsA not cont.

KEEPsAKE trial 1 (DMARD-IR) and 2 (DMARD/biologic-IR) on risankizumab (IL23i) for PsA: 👉some benefits of risankizumab for axial disease 👉no data regarding bowel disease 👉pts did remain on background DMARDS, steroids. (2/2)